| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 275.26B | 242.53B | 214.44B | 187.40B | 140.75B | 147.56B |
| Gross Profit | 224.34B | 196.70B | 176.30B | 165.06B | 134.65B | 131.90B |
| EBITDA | 87.77B | 71.05B | 56.79B | 40.29B | 43.62B | 37.66B |
| Net Income | 63.88B | 47.98B | 37.07B | 24.14B | 26.67B | 22.38B |
Balance Sheet | ||||||
| Total Assets | 13.60T | 13.52T | 14.83T | 12.96T | 13.34T | 12.16T |
| Cash, Cash Equivalents and Short-Term Investments | 2.93T | 3.03T | 3.72T | 3.60T | 4.05T | 2.75T |
| Total Debt | 2.24T | 2.18T | 3.29T | 3.05T | 3.59T | 2.32T |
| Total Liabilities | 12.53T | 12.55T | 13.71T | 12.05T | 12.43T | 11.25T |
| Stockholders Equity | 1.06T | 963.51B | 1.11T | 913.12B | 909.20B | 906.29B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 95.73B | -36.03B | 6.61B | 12.55B | 47.42B |
| Operating Cash Flow | 0.00 | 105.25B | -27.48B | 13.97B | 20.78B | 54.31B |
| Investing Cash Flow | 0.00 | 129.06B | -327.81B | -13.10B | -352.81B | -194.33B |
| Financing Cash Flow | 0.00 | -915.67B | 456.42B | -446.08B | 1.63T | 1.24T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥865.29B | 9.65 | 8.19% | 3.14% | 15.77% | 27.55% | |
75 Outperform | ¥1.28T | 19.77 | ― | 2.04% | 18.13% | 27.43% | |
70 Outperform | ¥956.28B | 10.74 | 6.30% | 2.87% | 14.57% | 100.81% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥963.92B | 8.76 | ― | 2.10% | 1.39% | 52.58% | |
66 Neutral | ¥1.26T | 8.94 | 8.24% | 3.06% | 12.77% | 9.22% | |
64 Neutral | ¥1.17T | 11.66 | ― | 2.00% | 18.45% | 41.89% |